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Adron Harris5, Rebecca Howard1.
1Skidmore College, Saratoga Springs, NY, USA, 2KTH, Stockhom, Sweden,
3Standford, Standford, CA, USA, 4Scilife Lab, Sweden, Sweden,
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Alcohol was recently shown to bind and modulate bacterial ligand-gated ion
channels related to neurologically important cys-loop receptors. These findings
provide useful models for alcohol modulation of brain receptors, but remain to
be confirmed in eukaryotic proteins at equivalent resolution. The recent deter-
mination of an X-ray structure of GluCl, a Caenorhabditis elegans receptor sub-
stantially closer to human proteins than existing bacterial structures, provides a
valuable opportunity to investigate alcohol modulation in a more relevant
model system. To test the utility of GluCl as a model for alcohol modulation,
we expressed the crystallized form of this receptor (GluClax) in Xenopus laevis
oocytes and characterized its function and modulation properties by two-
electrode voltage clamp electrophysiology. The modified homomeric receptor
exhibited limited glutamate sensitivity in the absence of ivermectin, consistent
with partial agonism. Preliminary data indicate glutamate activation is inhibited
by anesthetic concentrations of ethanol. Comparative modeling of prokaryotic
and eukaryotic receptors supports alcohol binding to transmembrane cavities
conserved throughout this family of proteins. In the long term, our results
will test the validity of GluCl as a model system to bridge the gap between
receptors of known structure and those of neurological importance, posing
opportunities for characterizing alcohol modulation of eukaryotic receptors
in structural detail. This work was supported by NIH/NIAAA grant R01
AA06399, Swedish Research Council grant VR 2010-491, European Research
Council grant ERC 209825, and by individual and collaborative research sup-
port from Skidmore College.
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Extracellular Contributions to Alcohol Modulation of Pentameric Ligand-
Gated Ion Channels
Amber Plante.
Chemistry, Skidmore College, Saratoga Springs, NY, USA.
The behavioral effects of alcohol action on the human brain are widely known,
but the mechanisms through which they occur are poorly understood. Glycine
receptors play a role in neuronal modulation by alcohol, however, the exact
molecular mechanisms through which this modulation occurs are unknown
due to difficulties in high-resolution imaging of receptor structures. Bacterial
receptor homolog, GLIC F238A, of known structure is modulated similarly
to Glycine receptors and may prove a useful model to further investigate
alcohol and anesthetic interactions with pentameric ligand-gated ion channels.
Recent studies have shown that residues in extracellular Loop 2, particularly
positions equivalent to D31 in GLIC, influence alcohol modulation in Glycine
receptors. Based on these results, we predicted that point mutations D31N and
D31S in Loop 2 in GLIC would reduce alcohol modulation of the GLIC F238A
model system. To test this prediction, we generated site-directed mutations to
quantify structural effects on ion channel gating and alcohol modulation using
two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes.
Preliminary results help to elucidate the role of Loop 2 in modulation of ion
channels throughout this family, and inform the validation of GLIC as a model
system for modulation of ligand-gated ion channels.
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Activation Mechanism of Elic by Propylamine
Alessandro Marabelli, Remigijus Lape, Lucia Sivilotti.
UCL, London, United Kingdom.
The pentameric ligand-gated channel ELIC has provided us with high resolu-
tion structures of its closed state. This prokaryotic channel opens to a high
single-channel conductance in response to a variety of amine compounds.
Here we report our tests of kinetic models for the activation of recombinant
ELIC channels. Outside-out single channel currents elicited by the full agonist
propylamine (0.5-50 mM) were analysed by maximum likelihood direct global
fitting of kinetic schemes (HJCFIT program; Colquhoun et al J Physiol 547,
699, 2003). The adequacy of a scheme was judged by comparing the predic-
tions of the best fit obtained for each, with the experimental open/shut time dis-
tributions and with the time course of macroscopic propylamine-activated
currents (fast theta-tube applications, 50-600 ms, 1-50 mM).
Other Cys-loop channels, such as glycine receptors, activate via a pre-opening
intermediate (’flip’ model, Burzomato et al., J Neurosci 24, 10924,2004) and,when fully liganded, open with high efficacy to a single open state. In contrast
with that, ELIC open time distributions at saturating propylamine showed more
than one component. Thus, more than one open state must be accessible to the
fully liganded channel. Theprimedmodel (Mukhtasimova et al., Nature 459,
451, 2009) accounts for that by allowing the channel to open from more than
one fully liganded intermediate. The best fit of this type of model showed
that ELIC maximum open probability (99%) is reached when three molecules
of agonist are bound. The overall efficacy of the fully liganded branch was
about 130 (c.f. 20 for a1b glycine channels; Burzomato et al., 2004).
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Pentameric ligand-gated ion channels are a large class of proteins involved in
electrochemical signal transduction. Signal transduction is a result of two pro-
cesses: (1) ligand binding to the receptor and (2) a conformational wave that
opens a pore far from the binding site (>20A˚). Recently, two prokaryotic mem-
bers of this family were identified, one from Gloeobacter violaceus (GLIC),
and one from Erwinia chrysanthemi (ELIC). These receptors provide a valu-
able platform for the study of ligand binding and channel gating in the Cys-
loop receptor family.
Receptors were expressed heterologously in Xenopus laevis oocytes, and
whole-cell voltage-clamp electrophysiology was used as a reporter for ligand
binding and channel gating. To examine the proton-binding event in GLIC,
unnatural amino acids were incorporated via nonsense-suppression with chem-
ically acylated tRNA. This approach provides a subtle probe of intrasubunit
interactions with the highly sensitive H11’ site, which has been previously
identified as necessary for the proton sensitivity of GLIC. A unique pair of pro-
line residues at the extracellular terminus of theM1 helix were also investigated
to examine potential intersubunit interactions that may play a role in channel
gating.
Despite the availability of putative "open" and "closed" X-ray structures of
GLIC and ELIC, the mechanism of gating is not yet clear. Gating is a dynamic
process initiated with ligand binding and resulting in conformational changes
and pore opening tens of angstroms away. To fully understand this process
will require a dynamic picture of the events that occur during the gating of
ion channels, which we ultimately aim to uncover using time-resolved fluores-
cence energy transfer. Progress towards the development of temporal control
for triggering channel opening/closing will be discussed.
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Biochemical and Functional Characterization of a Novel Prokaryote
Ligand-Gated Ion Channel CLIC
Mieke Nys, Radovan Spurny, Zander Claes, Chris Ulens.
KULeuven, Leuven, Belgium.
Crystal structures derived from acetylcholine binding proteins, prokaryotic and
invertebrate pentameric ligand-gated ion channels (pLGIC) have proven to be
valuable tools to study underlyingmechanisms concerning ligand binding, chan-
nel gating and ion permeation. The aim of this study is to further expand this
knowledge by identifying suitable targets for structural studies. Here we report
the identification of a novel prokaryotic pLGIC, referred to as CLIC. CLIC is
readily expressed in E.coli cells and can be extracted from the cell membrane
using detergents in a homogenous and monodisperse state. Purification using
a maltose-binding protein affinity tag and size-exclusion chromatography yields
milligram quantities of the receptor in a biochemically stable state. CLIC pro-
duces crystals within one week but the crystal diffraction quality is limited
due to anisotropic diffraction, which prevents structural elucidation. Extensive
optimization of crystal growth in the presence of different lipids and detergents
has failed to improve crystal diffraction.Wewill describe the biochemical prop-
erties of nanobody- and Fab-based complexes of CLIC to enhance crystal qual-
ity. In parallel, we have conducted a ligand screening using CLIC expressed in
Xenopus oocytes. We discovered several ligands that activate CLIC and can be
used as future tools in crystallization trials. Together, these results open perspec-
tives for the structure determination of novel prokaryote pLGICs.
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Utilizing Non-Equilibrium Methods to Probe the Effects of General
Anesthetics on Ligand-Gated Ion Channel Dynamics
Mark J. Arcario, Emad Tajkhorshid.
University of Illinois at Urbana-Champaign, Champaign, IL, USA.
Although anesthetics have been in use for over 150 years, the molecular mech-
anism behind their action is still poorly understood. Ligand-gated ion channels
546a Tuesday, February 18, 2014have been identified as the targets of these drugs, but it is unknown how anes-
thetics exert their effects. Previous simulations from our group have uncovered
a membrane-dependent entrance mechanism, whereby the anesthetic partitions
to the membrane prior to binding a transmembrane site identified in crystal
structures. To probe for additional binding sites unbiasedly and corroborate
the membrane-dependent entrance tunnel previously discovered, we have
used the "flooding" technique where the system is flooded with multiple copies
of the drug to increase the probability of observing binding events. Our simu-
lations elucidated not only the binding region indicated in crystal structures, but
also a novel second transmembrane binding site (TM2) observed consistently
across all subunits. The TM2 site is directly between the crystal structure site
(TM1) and the entrance tunnel elucidated in our simulations. Free energy
calculations show binding to the TM2 site increases the affinity of anesthetic
for the TM1 site in addition to acting as a physical barrier blocking the exit
of anesthetic from the protein. Moreover, anesthetic binding to the TM1/
TM2 sites induces an iris-like tilting of the M2 helix, as observed in our previ-
ous simulations, leading to constriction and dehydration of the conduction pore.
Utilizing umbrella sampling, this conformational change significantly increases
the barrier to conduction, prohibiting ion conduction in the dehydrated state.
Lastly, measurements of non-equilibrium work show that desflurane only mini-
mally perturbs the work required to induce constriction of the pore, while
greatly increasing the work needed for the dehydrated to open state transition.
This suggests that anesthetics stabilize the dehydrated state, but do not destabi-
lize the open state.
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Loose Packing of the Extracellular Domain Core of Pentameric Ligand-
Gated Ion Channels is Important for Fast Activation and Desensitization
Cosma D. Dellisanti, Cynthia Czajkowski.
University of Wisconsin - Madison, Madison, WI, USA.
Pentameric ligand-gated ion channels (pLGICs) mediate fast synaptic transmis-
sion. pLGIC activation is initiated by agonist binding to the orthosteric site in the
extracellular domain (ECD), which promotes rapid opening of a membrane-
embedded ion-conducting pore. Prolonged agonist exposure leads to pLGIC
desensitization, which results in channel closure. Eukaryotic pLGICs open in
the sub-millisecond to millisecond timescale, and transition into desensitized
closed states in tens of milliseconds. To date, we have limited knowledge of
the structural elements that underlie the rapid kinetics of activation and desen-
sitization in pLGICs.We previously showed that eukaryotic pLGICs are charac-
terized by loose packing of the ECD hydrophobic core, due to cavities created at
two conserved sites by buried side-chains of either polar residues (threonine and
serine in nicotinic receptors, nAChRs) or alanines (in GABA-A receptors), and
that increasing the packing of the ECD core at these two sites slowed agonist-
induced current activation and desensitization rates (Dellisanti et al., Nat
Neurosci 2007; Dellisanti and Czajkowski, J Biol Chem 2011). Interestingly,
prokaryotic pLGICs, like proton-activated GLIC, activate and desensitize
slowly and have a tightly packed ECD core. Here, we generated loose packing
mutants of GLIC by mutating V38 and V109 (aligned to nAChR-a1 T52 and
S126) to either alanines or threonine and serine, respectively. We expressed
the GLIC mutants in Xenopus oocytes and monitored the effects of these
mutations on proton-elicited currents using two-electrode voltage clamp. The
loose packingGLICmutants had 2- to 3-fold faster current activation and desen-
sitization rates compared to wild-type GLIC. The effects were larger when both
valines (V38AV109A and V38TV109S mutants) were mutated. Our data sug-
gest loose packing of the ECD core is directly implicated in fast activation
and desensitization of eukaryotic pLGICs.
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Construction and Characterization of a Functional GLIC-GABAr
Ligand-Gated Ion Channel Chimera
Borna Ghosh, Varun Tiwari, Cynthia Czajkowski.
Neuroscience, University of Wisconsin, Madison, Madison, WI, USA.
Pentameric ligand gated ion channels (pLGICs), especially anion-selective
GABAARs, are major targets of general anesthetic (GA) drugs. GAs mediate
their actions by binding in the transmembrane domain (TMD) of pLGICs,
which potentiates anion-selective pLGIC currents and inhibits cation-
selective pLGICs. Recently, crystal structures of prokaryotic cation-selective
pLGIC homologs, GLIC and ELIC, have been solved with several GAs bound.
High-resolution structures that reveal how GA’s interact with anion-selective
channels such as the GABAAR are not available, which justifies a quest for
pLGIC constructs that preserve GA positive modulation and are amenable
for structural studies.
Here, we report the construction and characterization of a GLIC-GABAr
chimeric pLGIC that is positively modulated by the GA pentobarbital. We
fused the extracellular domain (ECD) of the prokaryotic proton-gated homo-pentameric channel GLIC with the eukaryotic GABAr subunit TMD.
GABAAR r1 subunits form homopentameric channels making them ideal
for constructing chimeras with GLIC. The GLIC-r chimeric construct formed
functional proton-gated channels when expressed in Xenopus oocytes. The
reversal potential of the chimeric channels was 31mV, which is similar to
the reversal potential of GABAr receptors suggesting that the channel is
chloride-selective. GABAr receptors are normally insensitive or inhibited by
GAs but a point mutation in GABAr TMD W328M converts it to a channel
that is positively modulated by pentobarbital. When this mutation was made
in the GLIC-GABAr chimeric construct, the mutant chimeric channel was
directly gated by pentobarbital and proton-mediated currents were potentiated
by pentobarbital. Protocols for expressing and purifying high levels of the
GLIC-GABAr chimeric channel protein are currently being developed.
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Allosteric Modulation of GABA-A Receptors by Different Drugs
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Understanding how drugs allosterically modulate GABA-A receptor
(GABAAR) channel function remains a challenge. Anesthetic drugs like etomi-
date, propofol and pentobarbital bind at transmembrane domain (TMD) inter-
subunit interfaces at different locations. Benzodiazepines bind at the ag
interface in the extracellular domain (ECD) and neurosteroids are believed to
bind within the a-subunit TMD helix bundle. A common feature of these drugs
is that they potentiate GABA-induced currents. Here, we examined whether
structural mechanisms underlying their functional effects are distinct. We
monitored motions induced individually by these drugs at each inter-subunit
TMD interface and also tested whether modulation caused by pairs of drugs
binding to distinct sites are additive or super-additive.
We individually introduced a cysteine in the M1 helices of each subunit at
a1I227, b2L223 and g2LI238 to probe the different inter-subunit interfaces.
We expressed wild-type and mutant a1b2g2L GABAARs in Xenopus oocytes
and measured rates of modification of the substituted cysteines in the absence
and presence of GABA and different allosteric modulators: the anesthetics
pentobarbital (PB) and etomidate, the neurosteroid THDOC and the benzodiaz-
epine flurazepam. GABA activation significantly increased MTSEA modifica-
tion of aI227C, bL223C and gI238C. PB activation increased modification of
aI227C and gI238C but not bL223C. Modulating concentrations of PB or
etomidate had no effects. THDOC significantly increased the rate of modifica-
tion of bL223C whereas flurazepam increased gI238C modification. We found
that potentiation of EC10 GABA currents by combining modulating concentra-
tions of THDOC and flurazepam was the sum of the potentiation produced by
the two drugs individually. Combining PB and THDOC produced potentiation
more than the sum of the potentiation produced by the two drugs individually.
Our data suggests that drugs binding to different sites act via distinct mecha-
nisms. Further analysis is underway to determine if these mechanisms are inde-
pendent or coupled.
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Mechanism of Inhibition of Recombinant GABAA Receptors by Pentylene-
tetrazole and Its Alleviation by Anticonvulsants
Akimasa Iijima, Yongli Chen.
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Despite the wide prescription of drugs targeting postsynaptic g-aminobutyric
acid receptors (GABAARs) for seizure and epilepsy, mechanisms by which
those drugs exert their effects on GABAAR are poorly understood. This is
mainly attributed to the unavailability of crystal structure of the receptor and
the various assembly of 19 different subunits (a1- a6, b1-b3, g1-g3, d, ε, p,
q, r1-r3). Here, we studied the effects of two anticonvulsants on the recombi-
nant a1b3g2 GABAAR using whole-cell current recordings combined with
rapid kinetic techniques. Our results showed that pentylenetetrazole (PTZ), a
compound used to artificially induce convulsive effect in animal models, is a
mixed inhibitor of the receptor. Anticonvulsant ethosuximide (ES) and the
major metabolite (a-methyl-a-pheny-succinimide, MPS) of another anticon-
vulsant methsuximide (MS) were found to alleviate the inhibition of the recep-
tor by PTZ, while MS itself doesn’t. Those data suggest that the enhancement
of postsynaptic GABAAR response is one of the mechanisms of the anticonvul-
sant effect of ES and MS. T-type calcium channel was suggested to be one of
the targets of ES.
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